Emcure Pharmaceuticals Trades 1,634,517 Shares, Ranking Among Today's Most Active Equities
Emcure Pharmaceuticals Ltd has become one of the most actively traded stocks today, with a volume of over 1.6 million shares. Despite a decline in its stock price, investor participation has increased, and the stock remains above its 200-day moving average, indicating ongoing market interest.
Emcure Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active equities today. The stock, trading under the symbol EMCURE, recorded a total traded volume of 1,634,517 shares, with a total traded value of approximately Rs 21.83 crores. Opening at Rs 1,341, the stock experienced a notable decline, reaching a day's low of Rs 1,326, which represents a drop of 4.88%. The last traded price was Rs 1,344.6, reflecting a 3.60% decrease for the day, underperforming the sector's average decline of 0.46% and the Sensex's drop of 0.26%.
Despite this downturn, Emcure Pharmaceuticals remains above its 200-day moving average, although it is currently below its 5-day, 20-day, 50-day, and 100-day moving averages. Notably, there has been a rise in investor participation, with delivery volume on November 17 increasing by 26.12% compared to the 5-day average. The stock's liquidity is deemed sufficient for trading, based on 2% of the 5-day average traded value.
In summary, Emcure Pharmaceuticals has faced a challenging trading day, marked by significant activity and a decline in its stock price, while still maintaining a solid market presence.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
